1. Home
  2. IRIX vs APM Comparison

IRIX vs APM Comparison

Compare IRIX & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

N/A

Current Price

$0.92

Market Cap

20.2M

Sector

Health Care

ML Signal

N/A

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$1.29

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
APM
Founded
1989
2010
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
18.9M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
IRIX
APM
Price
$0.92
$1.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
105.3K
108.9K
Earning Date
11-11-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,647,000.00
N/A
Revenue This Year
$9.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.58
N/A
52 Week Low
$0.78
$0.65
52 Week High
$1.95
$7.49

Technical Indicators

Market Signals
Indicator
IRIX
APM
Relative Strength Index (RSI) 40.71 40.40
Support Level $0.90 $1.22
Resistance Level $0.97 $1.38
Average True Range (ATR) 0.06 0.13
MACD 0.00 0.00
Stochastic Oscillator 25.58 15.69

Price Performance

Historical Comparison
IRIX
APM

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: